The duration of effect depends on the active ingredient: Note: While traces may remain in your system longer, clinical effectiveness typically ends after the listed duration
This analysis excluded patients from STEP 4 as these were treated with semaglutide during the run-in phase
Once semaglutide is no longer in your system, blood sugar levels may rise to where they were before starting this medication
Ozempic (semaglutide) works by mimicking the action of GLP-1, a hormone that naturally occurs in the body
While there are newer and even more potent anti-obesity drugs on the horizon, semaglutide still garners attention for its non-diabetic and non-obesity benefits, specifically cardiovascular risk reduction, as well as improving renal outcomes [125,153]
The decision to cover or not cover GLP-1 obesity treatment options for employees and family members requires employers to weigh the clinical and financial implications